U.S. Chamber: Administration’s Price Controls on Drugs Will Leave America Unprepared for Next Pandemic


WASHINGTON, D.C. – U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley released the following statement today after the White House announcement on drug pricing:

“America’s pharmaceutical companies created safe, effective COVID vaccines in record time because of years of investments in research. The price controls proposed by the Biden administration are nothing more than a tax on the research investments that have made break-throughs, like the COVID vaccines, possible. Price controls will result in less research investment and fewer U.S. jobs, leaving America unprepared for the next public health crisis and delaying the development of treatments for cancer, Alzheimer’s and many other diseases. We will work to make sure these policies are not implemented.”

  OUR LATEST ON TWITTER

Global Innovation Policy Center (GIPC) @globalIPcenter 6h

On average, the worldwide trade in #counterfeit and pirated goods amounts to over $500 billion each year. Don’t buy into fake goods. #ShopSmart. @CBPTradeGov https://t.co/kpnXdhePAe https://t.co/kpnXdhePAe

Reply Retweet Favorite


Subscribe for updates from GIPC